CT-95
CNTX-CT95-101
Phase 1 small_molecule active
Quick answer
CT-95 for Mesothelin-Expressing Tumors is a Phase 1 program (small_molecule) at Context Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Context Therapeutics
- Indication
- Mesothelin-Expressing Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active